资讯

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...
The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...
The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...
GLP‑1 receptor agonists are widely recognized for aiding weight loss and controlling blood sugar, but access remains limited — especially for Medicare and Medicaid patients. That might change with a ...
Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...
The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Friday, citing documents from the Centers for Medicare and ...
Earlier this year, the Centers for Medicare and Medicaid Services scrapped a previous proposal, from the Biden administration ...